Earnings Negative

Avista Corp. Reports Strong Q3 2025 Financial Results, Confirms 2025 Earnings Guidance

Breaking news from global financial markets

il y a 3 jours
Lire Plus
Anika Reports Third Quarter 2025 Financial Results

Anika Reports Third Quarter 2025 Financial Results

Earnings
il y a 3 jours 2,856
Lire Plus
Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain

Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain

Technology
il y a 3 jours 1,343
Lire Plus
Pluristyx Executes Key Commercial Clinical Use Licenses for iPSC Portfolio, Enabling Novel Therapies for Regenerative Medicine and Neurological Disease Therapeutics

Pluristyx Executes Key Commercial Clinical Use Licenses for iPSC Portfolio, Enabling Novel Therapies for Regenerative Medicine and Neurological Disease Therapeutics

Technology
il y a 3 jours 3,539
Lire Plus
Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Technology
il y a 3 jours 4,515
Lire Plus
Bocana Resources Corp. provides Corporate Update

Bocana Resources Corp. provides Corporate Update

Markets
il y a 3 jours 2,736
Lire Plus
MVP Ventures Closes $125 Million Fund II, Reporting Top 5% TVPI Performance and Expanding Its Founder-First Model

MVP Ventures Closes $125 Million Fund II, Reporting Top 5% TVPI Performance and Expanding Its Founder-First Model

Markets
il y a 3 jours 1,801
Lire Plus
Stella-Jones Completes Acquisition of Brooks Manufacturing Co.

Stella-Jones Completes Acquisition of Brooks Manufacturing Co.

M&A
il y a 3 jours 656
Lire Plus
Stella-Jones Announces Normal Course Issuer Bid

Stella-Jones Announces Normal Course Issuer Bid

Regulations
il y a 3 jours 1,637
Lire Plus
Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing

Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing

Corporate
il y a 3 jours 1,276
Lire Plus
Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers

Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers

Regulations
il y a 3 jours 3,488
Lire Plus
Crown Crafts to Announce Second Quarter Fiscal Year 2026 Results on November 12, 2025

Crown Crafts to Announce Second Quarter Fiscal Year 2026 Results on November 12, 2025

Earnings
il y a 3 jours 4,205
Lire Plus
Eric Trump to Speak at Blockchain Futurist Conference Florida 2025

Eric Trump to Speak at Blockchain Futurist Conference Florida 2025

Crypto
il y a 3 jours 3,936
Lire Plus
Magna Announces Renewal of Normal Course Issuer Bid

Magna Announces Renewal of Normal Course Issuer Bid

Markets
il y a 3 jours 1,191
Lire Plus
Ocugen Provides Business Update with Third Quarter 2025 Financial Results

Ocugen Provides Business Update with Third Quarter 2025 Financial Results

Earnings
il y a 3 jours 1,051
Lire Plus
Magna Announces Renewal of Normal Course Issuer Bid

Magna Announces Renewal of Normal Course Issuer Bid

Regulations
il y a 3 jours 3,196
Lire Plus
H World Group Limited Schedules Third Quarter of 2025 Earnings Release on November 17, 2025

H World Group Limited Schedules Third Quarter of 2025 Earnings Release on November 17, 2025

Earnings
il y a 3 jours 3,528
Lire Plus
Housing Industry Responds to Budget 2025: “From a promise of 500,000 new homes – to a plan that will cost 100,000 jobs”

Housing Industry Responds to Budget 2025: “From a promise of 500,000 new homes – to a plan that will cost 100,000 jobs”

Corporate
il y a 3 jours 1,837
Lire Plus
Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare, Chronic, and Pre-Cancerous Genetic Skin Disease with No FDA-Approved Therapies

Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare, Chronic, and Pre-Cancerous Genetic Skin Disease with No FDA-Approved Therapies

Technology
il y a 3 jours 2,504
Lire Plus
Telix to Participate in UBS and Jefferies Global Healthcare Conferences

Telix to Participate in UBS and Jefferies Global Healthcare Conferences

Technology
il y a 3 jours 1,819
Lire Plus

Tendances Actuelles

1

IO DeFi Launches New Mobile App, Making BTC and XRP Hashrate Earnings Accessible...

21,141 il y a 1 jour
2

BPCE : Mise à disposition du troisième amendement au document d’enregistrement u...

14,309 il y a 1 jour
3

AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit w...

33,464 il y a 1 jour
4

BTCC November 2025 Product Update: Exchange Introduces Futures Pro Copy Trading

39,588 il y a 1 jour
5

4Thought Technologies CEO and EY Entrepreneur of the Year Award Nominee Richie S...

33,603 il y a 1 jour

Sujets Tendance

Sentiment (24h)

Positif
0
Neutre
0
Négatif
0